Andrew Fein joined C.E. Unterberg, Towbin in 2005 from Leerink Swann, a boutique health care firm where he was Vice President and a Senior Analyst in the biotechnology sector. Previously, Mr. Fein focused on the same sector at J.P. Morgan and Deutsche Bank.
Mr. Fein holds a BA in biology and history from Yale University. He completed a year of medical school at New York University before leaving to pursue finance.